TechFlow news, June 24 — According to PR Newswire, Synaptogenix (NASDAQ: SNPX), a biotech company listed on the U.S. stock market, announced the completion of its first TAO token acquisition as part of its recently disclosed cryptocurrency treasury strategy focused on artificial intelligence and machine learning. The company has selected digital asset infrastructure provider BitGo to provide qualified custody, staking, and trading services for its TAO holdings.
Synaptogenix Executive Chairman Joshua Silverman stated that under the guidance of James Altucher, the company's strategic lead for crypto TAO initiatives, the company has acquired the leading AI crypto token TAO and has begun staking the tokens to generate yield and capital appreciation. Synaptogenix has started generating revenue through TAO staking, with initial acquisition funds drawn from the company’s ample cash reserves.
